Business Description
SI-BONE Inc
NAICS : 334510
SIC : 3845
ISIN : US8257041090
Total Employee Number:
376Description
SI-BONE Inc is a medical device company that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ, and iFuse Bedrock Granite, which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 3.37 | |||||
Equity-to-Asset | 0.74 | |||||
Debt-to-Equity | 0.24 | |||||
Debt-to-EBITDA | -5.35 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 6.38 | |||||
Beneish M-Score | -2.81 | |||||
WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 14.6 | |||||
3-Year EBITDA Growth Rate | 46.6 | |||||
3-Year EPS without NRI Growth Rate | 37.4 | |||||
3-Year FCF Growth Rate | 47.9 | |||||
3-Year Book Growth Rate | 12.8 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 18.64 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 14.94 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 61.29 | |||||
9-Day RSI | 61.09 | |||||
14-Day RSI | 61.41 | |||||
3-1 Month Momentum % | 12.73 | |||||
6-1 Month Momentum % | -9.35 | |||||
12-1 Month Momentum % | -9.88 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 9.99 | |||||
Quick Ratio | 8.34 | |||||
Cash Ratio | 6.73 | |||||
Days Inventory | 294.43 | |||||
Days Sales Outstanding | 49.02 | |||||
Days Payable | 59.51 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -7.9 | |||||
Shareholder Yield % | -0.06 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 79.59 | |||||
Operating Margin % | -9.67 | |||||
Net Margin % | -8.1 | |||||
EBITDA Margin % | -3.89 | |||||
FCF Margin % | -2.69 | |||||
OCF Margin % | 0.91 | |||||
ROE % | -9.64 | |||||
ROA % | -7.11 | |||||
ROIC % | -25.71 | |||||
3-Year ROIIC % | 131.41 | |||||
ROC (Joel Greenblatt) % | -21.63 | |||||
ROCE % | -6.72 | |||||
Moat Score | 4 | |||||
Tariff Resilience Score | 7 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 3.62 | |||||
PB Ratio | 4.29 | |||||
Price-to-Tangible-Book | 4.29 | |||||
Price-to-Operating-Cash-Flow | 395.01 | |||||
EV-to-EBIT | -47.32 | |||||
EV-to-EBITDA | -83.33 | |||||
EV-to-Forward-EBITDA | 44.08 | |||||
EV-to-Revenue | 3.24 | |||||
EV-to-Forward-Revenue | 2.95 | |||||
EV-to-FCF | -120.66 | |||||
Price-to-GF-Value | 0.85 | |||||
| Price-to-Net-Current-Asset-Value | 5.1 | |||||
| Price-to-Net-Cash | 9.5 | |||||
Earnings Yield (Greenblatt) % | -2.11 | |||||
FCF Yield % | -0.72 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:SIBN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
SI-BONE Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 206.223 | ||
| EPS (TTM) ($) | -0.39 | ||
| Beta | 1.2798 | ||
| 3-Year Sharpe Ratio | -0.21 | ||
| 3-Year Sortino Ratio | -0.33 | ||
| Volatility % | 50 | ||
| 14-Day RSI | 61.41 | ||
| 14-Day ATR ($) | 0.799521 | ||
| 20-Day SMA ($) | 16.8465 | ||
| 12-1 Month Momentum % | -9.88 | ||
| 52-Week Range ($) | 11.48 - 21.89 | ||
| Shares Outstanding (Mil) | 44.35 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
SI-BONE Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
SI-BONE Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-10 16:30 | In 117 days | ||
| Third quarter earnings results for 2026 | 2026-11-10 | In 116 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-04 16:30 | In 19 days | ||
| Second quarter earnings results for 2026 | 2026-08-04 | In 18 days | ||
| Guidance call for 2026 | 2026-06-16 08:40 | 15.12 (-1.88%) | ||
| General meeting for 2026 | 2026-06-04 08:00 | 13.92 (-0.57%) | ||
| Guidance call for 2026 | 2026-05-12 08:00 | 11.61 (-6.14%) | ||
| First quarter earnings conference call for 2026 | 2026-05-11 16:30 | 12.27 (-5.25%) | ||
| First quarter earnings results for 2026 | 2026-05-11 | 12.27 (-5.25%) | ||
| TD Cowen 46th Annual Health Care Conference | 2026-03-02 10:30 | 15.52 (-3.00%) |
Show
Entries
SI-BONE Inc Frequently Asked Questions
What is SI-BONE Inc(SIBN)'s stock price today?
The current price of SIBN is $17.38. The 52 week high of SIBN is $21.89 and 52 week low is $11.48.
When is next earnings date of SI-BONE Inc(SIBN)?
The next earnings date of SI-BONE Inc(SIBN) is 2026-08-04 Est..
Does SI-BONE Inc(SIBN) pay dividends? If so, how much?
SI-BONE Inc(SIBN) does not pay dividend.
Guru Commentaries on NAS:SIBN
No articles.
Press Release
Articles on SI-BONE Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers